Mechanisms involved in the tumor-promoting effect of the CD154–CD40 dyad include activation of NF-κB and enhancing the production of angiogenic/growth factors such as platelet-activating factor (PAF) [78,79,80,81]. The gene discussed is CD40LG; the disease is neoplasm.